{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:01:10Z","timestamp":1794031270316,"version":"4.8.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/01\/COE\/07\/03 for Ancillary R&D 1"],"award-info":[{"award-number":["BT\/01\/COE\/07\/03 for Ancillary R&D 1"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bilateral ocular surface disease resulting from Stevens Johnson Syndrome (SJS) and chemical injuries are visually debilitating and difficult to treat. Ocular surface reconstruction by various means has been reported with variable results. This study addresses an unmet need for a prospective clinical trial comparing the outcomes of transplanting autologous oral and conjunctival epithelial cell constructs on human amniotic membrane by ex vivo tissue engineering.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective, randomized controlled clinical trial was prospectively applied for registration, with the clinical trial registry of India\u00a0(CTRI), with the approval of the Institute Ethics Committee number IEC\/NP-99\/11.04.2014 and CTRI No. REF\/2018\/10\/021791, the study also registered with the WHO-recognized trial registry, International Standard Randomised Controlled Trial Number (ISRCTN) registration reference number 45780. The study was conducted to compare clinical outcomes of two different tissue-engineered cell grafts, Cultivated Oral Mucosal Epithelial Transplantation (COMET) and Conjunctival Cultivated Epithelial Transplantation (CCET) for ocular surface reconstruction in patients with bilateral ocular surface disease due to Stevens-Johnson Syndrome or chemical injuries. Fifty patients were enrolled and randomized to either the COMET or CCET group. A uniform pre-op and post-op protocol using standard medications was followed for all patients Parameters assessed at baseline, day 1, 1 week, 2 weeks, 1 month, 2 months, 3 months and 6 months postoperatively included patient comfort, best corrected visual acuity (BCVA), ocular surface status and corneal clarity. The efficacy was measured in terms of improvement of vision, reduction in vascularization, symblepharon and corneal clarity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the study, 50 patients (50 eyes; mean ages of 29\u2009\u00b1\u200915.86 years and 26.36\u2009\u00b1\u200910.85 years, respectively; range, 12\u201365 years) were enrolled, with 25 patients each in the COMET and CCET groups. Out of them, 36% were female and 64% were male; the causes were Steven Johnson syndrome (48), and chemical injury (2). Mean pre-operative BCVA was log MAR 1.73\u2009\u00b1\u20090.57 for COMET and 1.99\u2009\u00b1\u20090.33 for the CCET group. Pre-operatively all 50 enrolled patients had opaque corneas pre-operatively, symblepharon that extended to the cornea categorised as grade 3\u00a0and corneal vascularization that went beyond the pupil\u2019s boundary into the central zone encluaching on the visual axis. The minimal follow-up time was six months. Following surgery postoperatively, the BCVA considerably improved in the COMET group by 1.51\u2009\u00b1\u20090.58 compared to the CCET group by 1.91\u2009\u00b1\u20090.33 at 3 months. BCVA at 6 months was 1.73\u2009\u00b1\u20090.56 in the COMET group and 1.99\u2009\u00b1\u20090.31 in the CCET group, which is not statistically significant and comparable to the BCVA before surgery. The corneal clarity was significantly improved in COMET group 25 eye (100%) at 2 month, 3month and 19 eye (76%), 6eye (24%) at 6 months when compared to CCET group 15 eye improved (60%), 9 eyes (36%) not improved and one eye with opaque cornea (4%) at 2 months. 22 eye (88%) had not improved, 2 eye (8%) opaque cornea and 1 eye (4%) improved at 3 months. At 6 months 21 eye (84%) were not improved, 4 eye (16%) eye became opaqued at 6 months. Compared to preoperative conditions, both groups had improved corneal clarity significantly (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.005). Of the 50 patients with grade 3 symblepharon extended to the cornea, were completely resolved 19 (76%) in COMET group when compared to CCET group 22 eye (88%) not improved. Similarly, 19 eye (76%) had a improvement in corneal vascularization when compared to the CCET group not improved 25 eye (100%) at 6months. No adverse event was observed in any of either group during the follow up periods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Both cell types are effective to restore the ocular surface integrity in bilateral ocular surface disease. Whereas COMET is safe and efficacious in terms of improvement of clinical parameters including, BCVA, corneal clarity, reduction in vascularization and preventing the recurrence of symblepharon postoperatively 3months and 6 months. In addition, the CCET group maintained the stability of the ocular surface and had improvement in corneal clarity and a decrease in vascularization at 3 months compared to their pre-operative characteristics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12896-024-00876-z","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T11:05:02Z","timestamp":1729249502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative evaluation of autologous tissue-engineered ocular and oral mucosal tissue grafts- a prospective randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Radhika","family":"Tandon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav Kumar","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer Alam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Kalaivani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misba","family":"Majood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neiwete","family":"Lomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noopur","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vanathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"876_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ophtha.2008.12.017","volume":"116","author":"HS Dua","year":"2009","unstructured":"Dua HS, Miri A, Alomar T, et al. The role of limbal stem cells in corneal epithelial maintenance: testing the dogma. Ophthalmology. 2009;116:856\u201363.","journal-title":"Ophthalmology"},{"key":"876_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2018.01.020","volume":"188","author":"J Vazirani","year":"2018","unstructured":"Vazirani J, Nair D, Shanbhag S, et al. Limbal Stem Cell Deficiency-Demography and underlying causes. Am J Ophthalmol. 2018;188:99\u2013103.","journal-title":"Am J Ophthalmol"},{"key":"876_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2018.10.016","volume":"199","author":"SH Choi","year":"2019","unstructured":"Choi SH, Kim MK, Oh JY. Corneal Limbal Stem Cell Deficiency in Children with Stevens-Johnson syndrome. Am J Ophthalmol. 2019;199:1\u20138.","journal-title":"Am J Ophthalmol"},{"key":"876_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jtos.2016.02.006","volume":"14","author":"J Vazirani","year":"2016","unstructured":"Vazirani J, Mariappan I, Ramamurthy S, et al. Surgical Management of bilateral Limbal Stem Cell Deficiency. Ocul Surf. 2016;14:350\u201364.","journal-title":"Ocul Surf"},{"key":"876_CR5","doi-asserted-by":"publisher","first-page":"836009","DOI":"10.3389\/fmed.2022.836009","volume":"9","author":"A Kate","year":"2022","unstructured":"Kate A, Basu S. A review of the diagnosis and treatment of Limbal Stem Cell Deficiency. Front Med (Lausanne). 2022;9:836009.","journal-title":"Front Med (Lausanne)"},{"key":"876_CR6","doi-asserted-by":"publisher","first-page":"9548","DOI":"10.1167\/iovs.11-7946","volume":"52","author":"S Sen","year":"2011","unstructured":"Sen S, Sharma S, Gupta A, et al. Molecular characterization of explant cultured human oral mucosal epithelial cells. Invest Ophthalmol Vis Sci. 2011;52:9548\u201354.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"876_CR7","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/ICO.0b013e3181dc81f1","volume":"30","author":"S Sharma","year":"2011","unstructured":"Sharma S, Tandon R, Mohanty S, et al. Culture of corneal limbal epithelial stem cells: experience from benchtop to bedside in a tertiary care hospital in India. Cornea. 2011;30:1223\u201332.","journal-title":"Cornea"},{"key":"876_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/08820530590931142","volume":"20","author":"M Dogru","year":"2005","unstructured":"Dogru M, Tsubota K. Current concepts in ocular surface reconstruction. Semin Ophthalmol. 2005;20:75\u201393.","journal-title":"Semin Ophthalmol"},{"key":"876_CR9","first-page":"5","volume":"52","author":"M Fernandes","year":"2004","unstructured":"Fernandes M, Sangwan VS, Rao SK, et al. Limbal stem cell transplantation. Indian J Ophthalmol. 2004;52:5\u201322.","journal-title":"Indian J Ophthalmol"},{"key":"876_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/sj.eye.6700670","volume":"18","author":"EM Espana","year":"2004","unstructured":"Espana EM, Di Pascuale M, Grueterich M, et al. Keratolimbal allograft in corneal reconstruction. Eye (Lond). 2004;18:406\u201317.","journal-title":"Eye (Lond)"},{"key":"876_CR11","first-page":"422","volume":"131","author":"S Krishnan","year":"2010","unstructured":"Krishnan S, Iyer GK, Krishnakumar S. Culture & characterisation of limbal epithelial cells & oral mucosal cells. Indian J Med Res. 2010;131:422\u20138.","journal-title":"Indian J Med Res"},{"key":"876_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1542-0124(12)70072-1","volume":"8","author":"AJ Shortt","year":"2010","unstructured":"Shortt AJ, Tuft SJ, Daniels JT. Ex vivo cultured limbal epithelial transplantation. A clinical perspective. Ocul Surf. 2010;8:80\u201390.","journal-title":"Ocul Surf"},{"key":"876_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1432-0436.1992.tb00690.x","volume":"51","author":"C Collin","year":"1992","unstructured":"Collin C, Ouhayoun JP, Grund C, et al. Suprabasal marker proteins distinguishing keratinizing squamous epithelia: cytokeratin 2 polypeptides of oral masticatory epithelium and epidermis are different. Differentiation. 1992;51:137\u201348.","journal-title":"Differentiation"},{"key":"876_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1083\/jcb.103.1.49","volume":"103","author":"A Schermer","year":"1986","unstructured":"Schermer A, Galvin S, Sun TT. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol. 1986;103:49\u201362.","journal-title":"J Cell Biol"},{"key":"876_CR15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/bjo.2010.188714","volume":"95","author":"T Nakamura","year":"2011","unstructured":"Nakamura T, Takeda K, Inatomi T, et al. Long-term results of autologous cultivated oral mucosal epithelial transplantation in the scar phase of severe ocular surface disorders. Br J Ophthalmol. 2011;95:942\u20136.","journal-title":"Br J Ophthalmol"},{"key":"876_CR16","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.ophtha.2011.01.039","volume":"118","author":"Y Satake","year":"2011","unstructured":"Satake Y, Higa K, Tsubota K, et al. Long-term outcome of cultivated oral mucosal epithelial sheet transplantation in treatment of total limbal stem cell deficiency. Ophthalmology. 2011;118:1524\u201330.","journal-title":"Ophthalmology"},{"key":"876_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10561-016-9575-4","volume":"17","author":"P Prabhasawat","year":"2016","unstructured":"Prabhasawat P, Ekpo P, Uiprasertkul M, et al. Long-term result of autologous cultivated oral mucosal epithelial transplantation for severe ocular surface disease. Cell Tissue Bank. 2016;17:491\u2013503.","journal-title":"Cell Tissue Bank"},{"key":"876_CR18","first-page":"236","volume":"36","author":"ZG Wei","year":"1995","unstructured":"Wei ZG, Cotsarelis G, Sun TT, et al. Label-retaining cells are preferentially located in fornical epithelium: implications on conjunctival epithelial homeostasis. Invest Ophthalmol Vis Sci. 1995;36:236\u201346.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"876_CR19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1167\/iovs.09-3379","volume":"51","author":"LP Ang","year":"2010","unstructured":"Ang LP, Tanioka H, Kawasaki S, et al. Cultivated human conjunctival epithelial transplantation for total limbal stem cell deficiency. Invest Ophthalmol Vis Sci. 2010;51:758\u201364.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"876_CR20","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/01.TP.0000127593.65888.A6","volume":"77","author":"DT Tan","year":"2004","unstructured":"Tan DT, Ang LP, Beuerman RW. Reconstruction of the ocular surface by transplantation of a serum-free derived cultivated conjunctival epithelial equivalent. Transplantation. 2004;77:1729\u201334.","journal-title":"Transplantation"},{"key":"876_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ophtha.2012.07.053","volume":"120","author":"C Sotozono","year":"2013","unstructured":"Sotozono C, Inatomi T, Nakamura T, Koizumi N, Yokoi N, Ueta M, Matsuyama K. Keiko Miyakoda, Hideaki Kaneda, Masanori Fukushima, Shigeru Kinoshita. Visual improvement after cultivated oral mucosal epithelial transplantation. Ophthalmology. 2013;120:193\u2013200.","journal-title":"Ophthalmology"},{"key":"876_CR22","doi-asserted-by":"crossref","unstructured":"Cabral JV, Jackson CJ. Tor Paaske Utheim, and Katerina Jirsova1.Ex vivo cultivated oral mucosal epithelial cell transplantation for limbal stem cell deficiency: a review. Stem Cell Research & Therapy. (2020) 11:301.","DOI":"10.1186\/s13287-020-01783-8"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-024-00876-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-024-00876-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-024-00876-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T11:07:26Z","timestamp":1729249646000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-024-00876-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1186\/s12896-024-00876-z","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"29 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institute Ethics Committee of All India Institute of Medical Sciences, New Delhi, India. (Reference No. IEC\/NP-99\/11.04.2014). The informed consent form obtained from all the patients. All procedures performed in this study involving human participants were in accordance with the Declaration of Helsinki by following the ICH-GCP guideline and national ICMR guidelines for Stem Cell Research and Therapy.Our study adheres to CONSORT guidelines and includes a completed CONSORT checklist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"REF\/2018\/10\/021791\u00a0dated 04\/10\/2018.\u00a0ISRCTN trial registration reference number 45780.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registry number"}},{"value":"Same as the corresponding author.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Address for reprint"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}